Copyright
©The Author(s) 2021.
World J Gastroenterol. Jan 7, 2021; 27(1): 80-91
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.80
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.80
Table 1 Baseline patient characteristics
Variable | All (n = 190) | AILDs (n = 114) | NAFLD (n = 66) |
Age, yr | 46.36 ± 12.82 | 48.72 ± 11.57 | 42.15 ± 13.80 |
Male sex, n (%) | 45 (23.68) | 23 (20.18) | 18 (27.27) |
BMI, kg/m2 | 23.97 ± 2.69 | 24.33 ± 1.80 | 23.63 ± 2.34 |
Prevalence of autoantibodies, n (%) | 134 (70.53) | 89 (78.07) | 37 (56.06) |
Laboratory | |||
AST, U/L | 63.96 ± 86.42 | 72.54 ± 102.23 | 54.6 ± 59.10 |
ALT, U/L | 83.86 ± 86.42 | 81.98 ± 92.78 | 92.81 ± 78.67 |
LDH, U/L | 182.70 ± 35.43 | 183.02 ± 37.39 | 182.64 ± 32.86 |
AKP, U/L | 80.00 (63.00, 108.50) | 85.00 (62.25, 129.5) | 75.00 (64.00, 94.00) |
GGT, U/L | 103.67 ± 126.83 | 126.00 ± 151.92 | 76.82 ± 73.15 |
Total bilirubin, mg/dL | 10.90 (8.10, 15.30) | 11.20 (8.30, 16.70) | 9.80 (6.95, 14.15) |
Direct bilirubin, mg/dL | 3.60 (2.80, 4.90) | 3.70 (2.90, 5.70) | 3.45 (2.52, 4.50) |
Histological steatosis stage, n (%) | |||
S0 (< 5%) | 22 (11.6) | 20 (11.1) | 0 (0.0) |
S1 (5%-33%) | 85 (44.7) | 61 (33.9) | 16 (24.2) |
S2 (> 33%-66%) | 55 (28.9) | 28 (15.6) | 27 (40.9) |
S3 (> 66%) | 28 (14.7) | 5 (2.8) | 23 (34.8) |
Histological fibrosis stage, n (%) | |||
F0 (no fibrosis) | 12 (6.3) | 1 (0.9) | 10 (15.2) |
F1 (portal fibrosis without septa) | 70 (36.8) | 38 (33.3) | 30 (45.5) |
F2 (portal and periportal fibrosis with few septa) | 64 (33.7) | 40 (35.1) | 18 (27.3) |
F3 (portal and periportal fibrosis with numerous septa without cirrhosis) | 35 (18.4) | 26 (22.8) | 8 (12.1) |
F4 (cirrhosis) | 9 (4.7) | 9 (7.9) | 0 (0.0) |
CAP, dB/m | 270.17 ± 54.52 | 261.73 ± 53.80 | 290.97 ± 50.68 |
LSM, kPa | 7.66 ± 5.57 | 8.48 ± 6.50 | 6.61 ± 3.66 |
- Citation: Ni XX, Lian M, Wu HM, Li XY, Sheng L, Bao H, Miao Q, Xiao X, Guo CJ, Li H, Ma X, Hua J. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases. World J Gastroenterol 2021; 27(1): 80-91
- URL: https://www.wjgnet.com/1007-9327/full/v27/i1/80.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i1.80